Products / Services
  • Products / Services
  • Companies
  • Buy Leads
    Post Buy Requirement

    Jakavi Ruxolitinib Tablet 20 Mg

    • Business TypeService Provider
    • Preferred Buyer Location All over the world

    56 Tablets/box Cancer Jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis.  
    Send Enquiry

    Company Information

    • calendar Member Since 1 Year
    • building Nature of Business Manufacturer
    • gst icon GST No. 09AAJCC5339A1ZT

    Ask for more detail from the seller

    Contact Supplier
    Report incorrect details
    Share your requirements for a quick response!
    Tell us what you need?
    To list your productBoost Your Business Visibility WorldwideRegister Now
    Waiting for permission
    To search by voice, go to your browser settings and allow access to microphone

    Allow microphone access to search with voice